cardiac size and function in acromegaly,' because of our recent observations on left ventricular dynamics in this disease.
Acromegaly and the Heart
To the Editor:
We were interested in the article by Martins and colleagues on cardiac size and function in acromegaly,' because of our recent observations on left ventricular dynamics in this disease.
Using echocardiography, we have studied a series of 24 patients, of whom seven were studied one year after elective surgery. All patients had markedly elevated growth hormone levels (16-380 ng/ml without suppression after glucose loading) in the preoperative assessment, with a normalization with postoperative data.
Every case exhibited a marked concentric left ventricular hypertrophy (LVH) with a mean LV free wall thickness of 16 mm and absolute LV mass of 484 g, according to the ellipse approximation calculations. None had signs of asymmetric septal hypertrophy. In the postoperative group of seven patients the LV wall thickness was smaller (13 mm, P < 0.001) but the mean LV mass did not differ from the preoperative data (477 g; NS). The mean LV transversal diameter was 51.7 ± 5.1 mm in the preoperative studies and 57.4 ± 4.5 mm in the postoperative studies (P < 0.05).
Asynergy was detected by multidirectional contraction cinetics analysis2 in only two patients. They also exhibited ischemic ST segment depressions upon exercise testing.
The data suggest that the acromegalic heart disease consists of concentric hypertrophy without other structural or functional abnormalities. It appears that normalization of the growth hormone levels postoperatively initiates dilatation with persistence of the increased LV mass.
M We feel that it is sometimes useful to continue exercise beyond a 0.1 MV depression if the patient is asymptomatic. Arrhythmias, chest pain or more severe ST depressions may appear and yield important diagnostic information.' Therefore, could the authors please comment on their definition of marked ST changes? If these marked changes are greater than the 0.1 MV ST depression for a positive test, is the prognostic stage the first positive stage or the final stage with symptoms, arrhythmias or "marked" ST The authors reply: To the Editor: In our analyses, we used the stage during which the test was stopped, not the stage during which the test became electrocardiographically positive. Approximately 13% of our positive tests were terminated because of "marked" ST segment changes. The definition of "marked" is subjective. In general, ST segment changes of greater than 0.4 MV or rapidly changing ST segment depression were grounds for stopping the test in the absence of symptoms.
We agree that it is often useful to continue exercise beyond 0.1 MV depression if the patient is asymptomatic. The recent paper by Mintz et al.1 presents interesting data to support their contention that "SAM (systolic anterior motion) of the mitral valve, systolic septal-mitral valve apposition, and IHSS (idiopathic hypertrophic subaortic stenosis) hemodynamics can exist in the absence of an echocardiographically demonstrable thickened septum." It should be pointed out that an outflow tract gradient was demonstrated in only four of 10 patients. In two of the remaining six patients no direct or indirect hemodynamic studies were done. In the other four patients the evidence for outflow obstruction was a prolongation of left ventricular ejection time (LVET) greater than 40 msec after amyl nitrite. We have recently published data2 which suggest that LVET prolongation after amyl nitrite is not the specific marker of IHSS hemodynamics that it has previously been reported to be by Cohn et al.
Eighteen normal males were found to have a mean LVET prolongation of 46 msec. Seventeen normal females had a mean LVET prolongation of 15 msec. This data is confirmed by the previous work of Sawayama et al.,4 who found an LVET increase of 45 msec in an all-male group. Nine of the 18 males (50%) had an LVET prolongation of greater than 40 msec. There was no statistical difference (P > 0.1) when the mean LVET prolongation of our normal male subjects was compared to the IHSS patients of Cohn. Since the majority of the patients of Mintz et al. were male, the finding of LVET prolongation greater than 40 msec in four patients is entirely compatible with a normal response in male patients. Therefore, evidence for outflow obstruction was demon-
